Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,594 | 37,924 | 32,478 | 23,147 | 3,823 |
| Depreciation Amortization | 16,879 | 15,987 | 11,759 | 12,848 | 12,615 |
| Income taxes - deferred | -2,437 | 1,543 | N/A | N/A | -8,210 |
| Accounts receivable | 19,723 | -15,272 | -2,431 | 9,357 | -22,031 |
| Accounts payable and accrued liabilities | -4,965 | 3,270 | -7,648 | -1,387 | 11,311 |
| Other Working Capital | 2,615 | -30,671 | -6,703 | -6,174 | 618 |
| Other Operating Activity | -1,722 | 24,071 | 14,688 | -994 | 21,266 |
| Operating Cash Flow | $72,687 | $36,852 | $42,143 | $36,797 | $19,392 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,019 | 0 | N/A | N/A | N/A |
| PPE Investments | -3,186 | -4,068 | -4,239 | -1,825 | -2,246 |
| Net Acquisitions | -15,849 | -14,284 | -4,925 | -18,600 | -55,123 |
| Purchase Sale Intangibles | -210 | -1,126 | -1,481 | -1,875 | -5,094 |
| Other Investing Activity | -210 | -1,126 | -1,481 | -1,875 | -5,094 |
| Investing Cash Flow | $-53,264 | $-19,478 | $-10,645 | $-22,300 | $-62,463 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 16,000 | 0 | N/A | N/A | 11,300 |
| Debt Issued | 140,000 | 0 | N/A | 35,383 | 25,000 |
| Debt Repayment | -16,000 | 0 | -38,017 | -52,226 | -4,359 |
| Common Stock Issued | 3,630 | 10,258 | 16,210 | 8,981 | 1,857 |
| Common Stock Repurchased | -19,289 | -11,525 | -4,633 | N/A | N/A |
| Other Financing Activity | -5,924 | 2,099 | 5,526 | 25,109 | -381 |
| Financing Cash Flow | $118,417 | $832 | $-20,914 | $17,247 | $33,417 |
| Exchange Rate Effect | -6,758 | -2,295 | -132 | 1,305 | -105 |
| Beginning Cash Position | 82,469 | 66,558 | 56,106 | 23,057 | 32,816 |
| End Cash Position | 213,551 | 82,469 | 66,558 | 56,106 | 23,057 |
| Net Cash Flow | $131,082 | $15,911 | $10,452 | $33,049 | $-9,759 |
| Free Cash Flow | |||||
| Operating Cash Flow | 72,687 | 36,852 | 42,143 | 36,797 | 19,392 |
| Capital Expenditure | -3,186 | -4,068 | -4,239 | -1,825 | -2,246 |
| Free Cash Flow | 69,501 | 32,784 | 37,904 | 34,972 | 17,146 |